{"id":5845,"date":"2024-06-14T02:15:37","date_gmt":"2024-06-14T02:15:37","guid":{"rendered":"https:\/\/exam.pscnotes.com\/current-affairs\/?p=5845"},"modified":"2024-06-14T02:15:37","modified_gmt":"2024-06-14T02:15:37","slug":"aurigene-pharma-to-invest-rs-330-crore-in-hyderabads-genome-valley","status":"publish","type":"post","link":"https:\/\/exam.pscnotes.com\/current-affairs\/aurigene-pharma-to-invest-rs-330-crore-in-hyderabads-genome-valley\/","title":{"rendered":"Aurigene Pharma to invest Rs 330 crore in Hyderabads Genome Valley"},"content":{"rendered":"

Dr Reddys Laboratories arm Aurigene Pharmaceutical Services<\/a> Ltd (APSL) plans to invest $40 million (330 crore approx.) in setting up a development and manufacturing facility in Hyderabads Genome Valley.
The contract research, development and manufacturing services organisation (CDMO) is a step-down subsidiary of Dr Reddys Labs.<\/p>\n

The proposed facility will focus on Niche<\/a> areas such as therapeutic proteins, antibodies, and viral vectors, a communique put out byTelanganaindustries minister KT Rama Raos office said after Dr Reddys Labs chairman Satish Reddy and APSL CEO AkhilRavimet him and briefed him about the upcoming project.<\/p>\n

The Dr Reddys top brass informed KTR that Aurigene

\r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n <\/svg>\r\n <\/span>\r\n Join Our Telegram Channel\r\n <\/a>\r\n <\/div> 48.6-11.4 42.9-11.4 132.3-11.4 132.3s0 89.4 11.4 132.3c6.3 23.7 24.8 41.5 48.3 47.8C117.2 448 288 448 288 448s170.8 0 213.4-11.5c23.5-6.3 42-24.2 48.3-47.8 11.4-42.9 11.4-132.3 11.4-132.3s0-89.4-11.4-132.3zm-317.5 213.5V175.2l142.7 81.2-142.7 81.2z\"\/>\r\n <\/svg>\r\n <\/span>\r\n Subscribe on YouTube\r\n <\/a>\r\n <\/div> would be collaborating with global biotech innovators to facilitate the development and introduction of innovative medicines into the market and the facility would generate about 200 direct jobs and another 60-70 indirect jobs within three years of the .<\/p>\n

The company also expects to significantly scale-up its investments in the future. KTR said Aurigenes investment is aligned perfectly with the Telangana<\/a> governments vision to enhance complex manufacturing at scale and will not only contribute to the Growth<\/a> of the biotherapeutics CDMO ecosystem in Hyderabad but will also reinforce the governments vision to promote the states biologics capabilities.<\/p>\n","protected":false},"excerpt":{"rendered":"

Dr Reddys Laboratories arm Aurigene Pharmaceutical Services Ltd (APSL) plans to invest $40 million (330 crore approx.) in setting up a development and manufacturing facility in Hyderabads Genome Valley. The contract research, development and manufacturing services organisation (CDMO) is a step-down subsidiary of Dr Reddys Labs. The proposed facility will focus on Niche areas such … Read more Aurigene Pharma to invest Rs 330 crore in Hyderabads Genome Valley<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1097],"tags":[656],"yoast_head":"\nAurigene Pharma to invest Rs 330 crore in Hyderabads Genome Valley - Current Affairs Exam<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/exam.pscnotes.com\/current-affairs\/2024\/06\/14\/aurigene-pharma-to-invest-rs-330-crore-in-hyderabads-genome-valley\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aurigene Pharma to invest Rs 330 crore in Hyderabads Genome Valley\" \/>\n<meta property=\"og:description\" content=\"Dr Reddys Laboratories arm Aurigene Pharmaceutical Services Ltd (APSL) plans to invest $40 million (330 crore approx.) in setting up a development and manufacturing facility in Hyderabads Genome Valley. The contract research, development and manufacturing services organisation (CDMO) is a step-down subsidiary of Dr Reddys Labs. The proposed facility will focus on Niche areas such ... Read more Aurigene Pharma to invest Rs 330 crore in Hyderabads Genome Valley\" \/>\n<meta property=\"og:url\" content=\"https:\/\/exam.pscnotes.com\/current-affairs\/2024\/06\/14\/aurigene-pharma-to-invest-rs-330-crore-in-hyderabads-genome-valley\/\" \/>\n<meta property=\"og:site_name\" content=\"Current Affairs Exam\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-14T02:15:37+00:00\" \/>\n<meta name=\"author\" content=\"rawan239\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rawan239\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Aurigene Pharma to invest Rs 330 crore in Hyderabads Genome Valley - Current Affairs Exam","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/exam.pscnotes.com\/current-affairs\/2024\/06\/14\/aurigene-pharma-to-invest-rs-330-crore-in-hyderabads-genome-valley\/","og_locale":"en_US","og_type":"article","og_title":"Aurigene Pharma to invest Rs 330 crore in Hyderabads Genome Valley","og_description":"Dr Reddys Laboratories arm Aurigene Pharmaceutical Services Ltd (APSL) plans to invest $40 million (330 crore approx.) in setting up a development and manufacturing facility in Hyderabads Genome Valley. The contract research, development and manufacturing services organisation (CDMO) is a step-down subsidiary of Dr Reddys Labs. The proposed facility will focus on Niche areas such ... Read more Aurigene Pharma to invest Rs 330 crore in Hyderabads Genome Valley","og_url":"https:\/\/exam.pscnotes.com\/current-affairs\/2024\/06\/14\/aurigene-pharma-to-invest-rs-330-crore-in-hyderabads-genome-valley\/","og_site_name":"Current Affairs Exam","article_published_time":"2024-06-14T02:15:37+00:00","author":"rawan239","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rawan239","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/exam.pscnotes.com\/current-affairs\/2024\/06\/14\/aurigene-pharma-to-invest-rs-330-crore-in-hyderabads-genome-valley\/","url":"https:\/\/exam.pscnotes.com\/current-affairs\/2024\/06\/14\/aurigene-pharma-to-invest-rs-330-crore-in-hyderabads-genome-valley\/","name":"Aurigene Pharma to invest Rs 330 crore in Hyderabads Genome Valley - Current Affairs Exam","isPartOf":{"@id":"https:\/\/exam.pscnotes.com\/current-affairs\/#website"},"datePublished":"2024-06-14T02:15:37+00:00","dateModified":"2024-06-14T02:15:37+00:00","author":{"@id":"https:\/\/exam.pscnotes.com\/current-affairs\/#\/schema\/person\/5807dafeb27d2ec82344d6cbd6c3d209"},"breadcrumb":{"@id":"https:\/\/exam.pscnotes.com\/current-affairs\/2024\/06\/14\/aurigene-pharma-to-invest-rs-330-crore-in-hyderabads-genome-valley\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/exam.pscnotes.com\/current-affairs\/2024\/06\/14\/aurigene-pharma-to-invest-rs-330-crore-in-hyderabads-genome-valley\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/exam.pscnotes.com\/current-affairs\/2024\/06\/14\/aurigene-pharma-to-invest-rs-330-crore-in-hyderabads-genome-valley\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/exam.pscnotes.com\/current-affairs\/"},{"@type":"ListItem","position":2,"name":"Aurigene Pharma to invest Rs 330 crore in Hyderabads Genome Valley"}]},{"@type":"WebSite","@id":"https:\/\/exam.pscnotes.com\/current-affairs\/#website","url":"https:\/\/exam.pscnotes.com\/current-affairs\/","name":"Current Affairs Exam","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/exam.pscnotes.com\/current-affairs\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/exam.pscnotes.com\/current-affairs\/#\/schema\/person\/5807dafeb27d2ec82344d6cbd6c3d209","name":"rawan239","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/exam.pscnotes.com\/current-affairs\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d97f17072bfa490596c8f78363955d55?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d97f17072bfa490596c8f78363955d55?s=96&d=mm&r=g","caption":"rawan239"},"sameAs":["https:\/\/exam.pscnotes.com"],"url":"https:\/\/exam.pscnotes.com\/current-affairs\/author\/rawan239\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/exam.pscnotes.com\/current-affairs\/wp-json\/wp\/v2\/posts\/5845"}],"collection":[{"href":"https:\/\/exam.pscnotes.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/exam.pscnotes.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/exam.pscnotes.com\/current-affairs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/exam.pscnotes.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=5845"}],"version-history":[{"count":0,"href":"https:\/\/exam.pscnotes.com\/current-affairs\/wp-json\/wp\/v2\/posts\/5845\/revisions"}],"wp:attachment":[{"href":"https:\/\/exam.pscnotes.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=5845"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/exam.pscnotes.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=5845"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/exam.pscnotes.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=5845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}